Table 2.

Demographics and clinical characteristics of patients for galectin-9 expression analysis in validation study

Characteristics	Rejection (n=73)	Non-rejection (n=63)	P-value
Age (years)	40.4±9.6	46.6±10.3	<0.05
Gender
Male	59 (80.8%)	56 (88.9%)	NS
Female	14 (19.2%)	7 (11.1%)
MELD score	23.8±10.0	21.8±10.4	NS
Child-Pugh score	10.2±2.3	9.3±2.3	<0.05
Serum creatinine (μmol/L)	83.3±64.3	108.9±140.2	NS
ABO compatibility (%)	62 (84.9%)	51 (81.0%)	NS
Time until rejection (d)	11.2±7.5

Data are expressed as number (percentage) or mean±SD. NS: not significant; MELD: model for end-stage liver disease